Yasmin Articles
Schering AG to "grow faster than market"
16 March 2001
Healthy harvest of New Chemical Entities in 2000
2 January 2001
Stock Commentary Europe
28 September 2000
Stock Commentary Europe
14 September 2000
Europe approves Schering's Yasmin, US approvable letter for Imavist
7 September 2000
FDA requests more data for Schering's Yasmin
20 July 2000
FDA requests more data for Schering's Yasmin
20 July 2000
Schering's Yasmin approved in the Netherlands
13 April 2000
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
